Xu Qiankun, Zheng Huilan, Zeng Fanchao, Li Bin, Huang Deliang, Cai Qiang, Yang Zhizhao, Wu Peng
Department of Urology, Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, China.
Department of Urology, Gongan County People's Hospital, Jingzhou, China.
Ir J Med Sci. 2025 Jun 18. doi: 10.1007/s11845-025-03987-4.
Identifying reliable predictors of postoperative renal insufficiency (PRI) following partial or radical nephrectomy for renal cell carcinoma (RCC) is critical for optimizing perioperative management.
We systematically searched MEDLINE, Cochrane Library, and Embase up to March 20, 2025, to identify cohort studies that evaluated the association between preoperative proteinuria and PRI. We calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs) using a random-effects model. Subgroup analyses were stratified by study design (prospective vs. retrospective) and surgical modality (partial vs. radical nephrectomy).
Six cohort studies involving 3124 patients were included. Preoperative proteinuria was significantly associated with an increased risk of PRI (OR = 2.69, 95% CI 1.48-4.89; I = 67.3%). We found that retrospective studies showed a stronger association between preoperative proteinuria and PRI (OR = 3.35, 95% CI 1.71-6.56) compared to prospective studies (OR = 1.89, 95% CI 0.98-3.66). Subgroup analysis by surgical approach revealed significant risk elevation in both partial nephrectomy (OR = 2.11, 95% CI 1.34-3.33) and radical nephrectomy cohorts (OR = 5.50, 95% CI 4.31-7.02), with a notably higher effect size in the latter.
Preoperative proteinuria is significantly associated with an elevated risk of PRI in patients undergoing nephrectomy for renal cell carcinoma. These findings emphasize the need to incorporate proteinuria assessment into preoperative risk evaluations to improve patient counselling and perioperative management. Future high-quality prospective studies, particularly multicenter investigations with standardized protocols, are essential to confirm these associations and explore the pathophysiological mechanisms underlying proteinuria-related renal functional decline.
确定肾细胞癌(RCC)部分或根治性肾切除术后发生术后肾功能不全(PRI)的可靠预测因素对于优化围手术期管理至关重要。
我们系统检索了截至2025年3月20日的MEDLINE、Cochrane图书馆和Embase,以确定评估术前蛋白尿与PRI之间关联的队列研究。我们使用随机效应模型计算了95%置信区间(CI)的合并比值比(OR)。亚组分析按研究设计(前瞻性与回顾性)和手术方式(部分肾切除术与根治性肾切除术)进行分层。
纳入了6项涉及3124例患者的队列研究。术前蛋白尿与PRI风险增加显著相关(OR = 2.69,95% CI 1.48 - 4.89;I = 67.3%)。我们发现,与前瞻性研究(OR = 1.89,95% CI 0.98 - 3.66)相比,回顾性研究显示术前蛋白尿与PRI之间的关联更强(OR = 3.35,95% CI 1.71 - 6.56)。按手术方式进行的亚组分析显示,部分肾切除术队列(OR = 2.11,95% CI 1.34 - 3.33)和根治性肾切除术队列(OR = 5.50,95% CI 4.31 - 7.02)的风险均显著升高,后者的效应量明显更高。
术前蛋白尿与接受肾细胞癌肾切除术患者的PRI风险升高显著相关。这些发现强调了将蛋白尿评估纳入术前风险评估以改善患者咨询和围手术期管理的必要性。未来高质量的前瞻性研究,特别是采用标准化方案的多中心研究,对于确认这些关联并探索蛋白尿相关肾功能下降的病理生理机制至关重要。